EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy [0.03%]
EASL临床实践指南：论妊娠期肝病的管理
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu;European Association for the Study of the Liver
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu;European Association for the Study of the Liver
Liver diseases in pregnancy comprise both gestational liver disorders and acute and chronic hepatic disorders occurring coincidentally in pregnancy. Whether related to pregnancy or pre-existing, liver diseases in pregnancy are associated wi...
Practice Guideline
Journal of hepatology. 2023 Sep;79(3):768-828. DOI:10.1016/j.jhep.2023.03.006 2023
Reply to: "Improved basic performance of iTACT-HBcrAg assay" and "Using a commercial diagnostic assay requires compliance with the manufacturer's recommendations" [0.03%]
对“iTAIC-HBcrAg检测性能改进”和“使用商业诊断试剂盒需遵循厂家建议”的答复
Seng Gee Lim,Ee Jin Yeo,Celina Adraneda et al.
Seng Gee Lim et al.
Dysregulation of the LPC-ATX-LPA axis in autoimmune hepatitis is associated with monocyte activation [0.03%]
自身免疫性肝炎中LPC-ATX-LPA轴失调与单核细胞活化相关
Fan Yang,Xiaoli Fan,Li Yang
Fan Yang
Early neurological worsening in Wilson disease: The need for an evidence-based definition [0.03%]
威尔森病早期神经恶化：需要一个基于证据的定义
Tomasz Litwin,Anna Członkowska,Lukasz Smolinski
Tomasz Litwin
Is it time to reconsider the MRP6 role in bile secretion and LPAC genetic signature? [0.03%]
是否需要重新考虑MRP6在胆汁分泌和LPAC遗传特征中的作用？
Mario Romeo,Marcello Dallio,Alessandro Federico
Mario Romeo
Target mean arterial pressure in critically ill cirrhotic patients with septic shock: More is not always better! [0.03%]
重症肝病患者脓毒性休克的目标平均动脉压：更高并不总是更好！
Dhiraj Agrawal,Kishore Kumar Ariga
Dhiraj Agrawal
Libor Vítek,Claudio Tiribelli
Libor Vítek
Gilbert's syndrome, also known as benign hyperbilirubinaemia, was described more than 100 years ago. It has usually been considered a physiological abnormality characterised by a mild elevation of the systemic level of unconjugated bilirubi...
Reply to: 'A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Has the correct patient cohort been targeted?' [0.03%]
对“乙型肝炎表面抗原血清学转换后肝细胞癌风险预测模型”的讨论——正确的研究对象人群了吗？
Hyun Yang,Ji Hoon Kim,Ji Won Han et al.
Hyun Yang et al.
Selection of patients with portal hypertension and cirrhosis who will benefit from beta-blockers: Still a current challenge [0.03%]
如何选择能够从β受体阻滞剂治疗中获益的门脉高压和肝硬化患者仍然具有挑战性
Ubiratan Cassano Santos,Maria das Graças Coelho de Souza,Guilherme Ferreira da Motta Rezende
Ubiratan Cassano Santos